Reference
All 125 peptides
Every profile uses the same structure: summary, benefits and side effects, vials and reconstitution, a phase-by-phase dosing table, lifestyle notes, identification and linked research.
125 results
AOD-9604
AOD 9604 · Tyr-hGH fragment 177-191
AOD-9604 is a fat-burning peptide that tricks your body into breaking down stored fat more efficiently, kind of like giving your metabolism a boost. It’s derived from human growth hormone but was specifically designed to avoid the side effects that regular growth hormone can cause.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 8–12 weeks
ARA-290
ARA290 · Cibinetide
ARA-290 is a next-generation repair peptide that fixes damaged nerves and calms down overactive inflammation, without the side effects of older anti-inflammatory drugs. It’s engineered from erythropoietin (the hormone that makes red blood cells), but scientists removed the blood-building part and kept only the healing and protective powers—making it unique among peptides.
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks
BPC-157
Bepecin · PL-14736
BPC-157, or Body Protective Compound-157, is a gut-healing and tissue-repair superhero that speeds up recovery from injuries while protecting your organs from damage. This peptide naturally occurs in stomach fluid and has been studied extensively for its ability to accelerate healing in muscles, tendons, ligaments, bones, and even the lining of your digestive system.
- Route
- Subcutaneous
- Dose
- 250 mcg – 1 mg
- Cycle
- 8–12 weeks
BPC-157, TB-500
The peptide blend of BPC-157 (Body Protection Compound) and TB-500 (a synthetic version of Thymosin Beta-4) is a popular combination in regenerative medicine, often referred to as the “Wolverine Stack” due to its potential to accelerate tissue repair. BPC-157 is a pentadecapeptide originally derived from human gastric juice, known for its “cytoprotective” properties and its ability to upregulate growth hormone receptors in fibroblasts.
- Route
- Subcutaneous
- Dose
- 333 mcg – 667 mcg
- Cycle
- 8–12 weeks
Cagrilintide
NN9838 (Novo Nordisk development code) · AM833 (development designation)
Cagrilintide is a next-generation weight-loss peptide engineered to control your appetite at the brain level, making you feel satisfied on less food without the jittery, nauseous side effects of older diet drugs. Unlike GLP-1 medications like semaglutide that target one appetite pathway, Cagrilintide activates amylin receptors—a different system your brain uses to know when you’re full and should stop eating.
- Route
- Subcutaneous
- Dose
- 300 mcg – 1.2 mg
- Cycle
- Long-term management focus
CJC-1295 (No DAC)
No DAC
CJC-1295 without DAC, also called Mod GRF 1-29, is a refined growth hormone-releasing hormone analog that creates natural-feeling GH pulses to boost muscle repair, fat metabolism, and youthful vitality without constant elevation. Unlike the DAC version that lingers for days, no-DAC provides short 30-60 minute bursts mimicking your pituitary’s natural response during deep sleep or exercise, preserving sensitivity and avoiding receptor fatigue.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC), Ipamorelin
No DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) and Ipamorelin form a clean, beginner-friendly GH duo that gently amplifies your natural growth hormone pulses for muscle growth, fat loss, and recovery without the hunger or side effects of stronger secretagogues. CJC-1295 mimics the brain’s GH-releasing hormone for short, physiologic bursts, while Ipamorelin selectively activates GH pathways without raising cortisol, prolactin, or appetite—making it one of the safest options.
- Route
- Subcutaneous
- Dose
- 333 mcg – 2 mg
- Cycle
- 12–16 weeks
DSIP
DSIP, or Delta Sleep-Inducing Peptide, is a natural sleep helper that your body makes to promote deep, restorative rest without the grogginess of sleeping pills. It works by balancing brain chemicals and hormones like serotonin and corticotropin, calming stress signals while boosting slow-wave sleep—the deepest phase where your body repairs muscles, strengthens your immune system, and clears mental fog.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 8–12 weeks
Epithalon (Epitalon)
Epitalon
Epithalon, also called Epitalon, is a tiny peptide that activates your body’s built-in anti-aging system by lengthening telomeres—the protective caps on your chromosomes that shorten with age, causing cells to age and die prematurely. Discovered from the pineal gland, it boosts telomerase enzyme activity, essentially turning back the cellular clock to keep cells youthful and functional longer.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1 mg
- Cycle
- 20-day "pulse" repeated every 6 months
GHK-Cu (Copper Peptide)
Copper Peptide
GHK-Cu is a regenerative powerhouse peptide that rebuilds collagen, accelerates wound healing, and triggers anti-aging effects by remodeling skin at the genetic level. The copper component acts as a critical cofactor for enzymes responsible for collagen cross-linking—making collagen strong and flexible—while GHK itself signals cells to produce new collagen, elastin, and other structural proteins.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks
Glow – BPC-157, TB-500, GHK-Cu
Glow is a premium combination formula blending three powerhouse peptides: BPC-157 for localized tissue repair and gut healing, TB-500 for systemic recovery and inflammation control, and GHK-Cu for collagen regeneration and skin rejuvenation. Together, they create a synergistic healing effect that addresses both deep tissue repair and surface-level skin radiance.
- Route
- Subcutaneous
- Dose
- 100 mcg – 3 mg
- Cycle
- 8–12 weeks
Glutathione
Glutathione is your body’s master antioxidant and detoxification molecule—a powerful tripeptide that binds to toxins, heavy metals, and free radicals to render them harmless and eliminate them through the liver and kidneys. It’s the body’s primary defense against oxidative stress, the process where free radicals damage cells and accelerate aging, disease, and inflammation.
- Route
- Subcutaneous
- Dose
- 150 mg – 600 mg
- Cycle
- 4–8 weeks
IGF-1 LR3
IGF-1 LR3 is a long-acting variant of insulin-like growth factor 1 designed to remain active in your bloodstream for hours rather than minutes, delivering sustained muscle-building, fat-burning, and anti-aging effects. The “LR3” refers to a structural modification that extends its half-life dramatically, allowing one injection to provide extended anabolic signaling throughout your body.
- Route
- Subcutaneous
- Dose
- 100 mcg
- Cycle
- 4–8 weeks
Ipamorelin
Ipamorelin is a clean, selective growth hormone secretagogue that gently stimulates your pituitary to release GH in natural, pulsatile patterns that preserve your body’s feedback loops and avoid receptor fatigue. Unlike aggressive peptides like GHRP-2 that trigger hunger and multiple hormones, Ipamorelin specifically targets GH release without stimulating appetite, prolactin, or cortisol—making it ideal for those seeking muscle and fat-loss gains without side effects.
- Route
- Subcutaneous
- Dose
- 100 mcg – 250 mcg
- Cycle
- 8–12 weeks
Kisspeptin-10
Kisspeptin-10 is a reproductive hormone peptide that directly activates the hypothalamic-pituitary-gonadal (HPG) axis to stimulate luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release, restoring natural reproductive function and testosterone or estrogen production. It works by binding to kisspeptin receptors in the brain, triggering the release of GnRH (gonadotropin-releasing hormone), which cascades into full reproductive hormone release—essentially reawakening your body’s natural fertility and sex hormone factories.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 8–12 weeks
Klow – BPC-157, TB-500, KPV, GHK-Cu
Klow is an advanced four-peptide formula combining BPC-157 (tissue repair), TB-500 (systemic healing), KPV (anti-inflammatory), and GHK-Cu (collagen and skin regeneration) for comprehensive healing and immune regulation. This potent blend targets inflammation at its source, repairs tissues at multiple levels, and restores skin health while modulating your immune system intelligently.
- Route
- Subcutaneous
- Dose
- 200 mcg – 2 mg
- Cycle
- 8–12 weeks
KPV (Ac-KPV-NH2)
Ac-KPV-NH2
KPV is a tiny three-amino-acid peptide derived from alpha-MSH that acts as a precision anti-inflammatory tool, calming dangerous inflammation at its source without suppressing your immune system’s ability to fight infections. It works by blocking NF-κB, the master switch that turns on inflammatory cascade reactions, while also reducing production of pro-inflammatory cytokines like TNF-α and IL-6.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 8–12 weeks
LL-37
LL-37 is a powerful 37-amino-acid antimicrobial peptide that serves as your first-line defense against bacteria, fungi, and viruses by directly disrupting their cell membranes and preventing infection. It’s constitutively produced in your skin, lungs, and immune cells, forming a protective barrier that keeps harmful microbes from gaining foothold.
- Route
- Subcutaneous
- Dose
- 50 mcg – 200 mcg
- Cycle
- 8–12 weeks
MOTS-c
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a mitochondrial-derived hormone peptide discovered to be released during exercise that awakens your cells’ power generators to burn fuel more efficiently, build muscle faster, and resist aging at the metabolic level. This 16-amino acid “mitokine” transfers to your cell nucleus during metabolic stress to activate protective genes, simultaneously boosting glucose uptake into muscles via AMPK activation, reducing inflammation, and protecting your heart and brain from oxidative damage—essentially molecular exercise in a syringe.
- Route
- Subcutaneous
- Dose
- 200 mcg – 1 mg
- Cycle
- 8–12 weeks
NAD+
NAD+ (Nicotinamide Adenine Dinucleotide) is your cells’ universal energy and repair currency, essential for ATP production, DNA damage repair, mitochondrial function, epigenetic gene expression, and activation of sirtuins—the “longevity genes” that slow aging at the molecular level. NAD+ levels decline 50% by age 50, explaining why aging tissues struggle with repair, energy production, and disease resistance.
- Route
- Subcutaneous
- Dose
- 50 mg – 100 mg
- Cycle
- 8–16 weeks
Pinealon
Pinealon is a triamino-acid peptide complex (Glu-Asp-Gly) that restores pineal gland function to reestablish youthful circadian rhythms, melatonin production, and neuroprotection against age-related cognitive decline and neurodegeneration. Working at the epigenetic level, it regulates gene expression in brain cells to support cellular metabolism, antioxidant defense, and neuronal plasticity—the foundation of memory, learning, and resilience to stress and aging.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 8–12 weeks
PT-141 (Bremelanotide)
Bremelanotide
PT-141 is a melanocortin agonist peptide approved by the FDA for women’s sexual desire disorder that activates brain melanocortin receptors (particularly MC3R and MC4R) to “flip the central switch” for sexual arousal and erectile response, working through fundamentally different pathways than Viagra and serving as effective salvage therapy for those failing conventional ED medications. Phase 2-3 clinical trials show 33.5% of men with sildenafil-resistant erectile dysfunction achieved functional erections on PT-141 versus 8.5% placebo—a genuine breakthrough for treatment-refractory cases—while also improving desire, sexual confidence, and orgasmic function.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1.75 mg
- Cycle
- Use as needed; maximum of 8 doses per month is standard in clinical settings
Retatrutide
Retatrutide is the first triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously to deliver superior weight loss and metabolic improvement exceeding any single or dual-agonist therapy—achieving 24.2% weight loss (approximately 50+ pounds) in individuals with obesity over 48 weeks and 16.9% in those with type 2 diabetes, with hepatic steatosis resolution in 85% of participants.
- Route
- Subcutaneous
- Dose
- 2 mg – 12 mg
- Cycle
- Titrate every 4 weeks
Selank
Selank is a heptapeptide anxiolytic derived from tuftsin with clinical efficacy equal to benzodiazepine anxiolytics but without sedation, dependence, or cognitive impairment, working through GABAergic enhancement and serotonergic/dopaminergic modulation to create calm without dulling mental clarity. Research shows it reduces generalized anxiety disorder and PTSD symptoms while preserving or enhancing cognitive performance—a combination rarely achieved by conventional psychiatric medications.
- Route
- Subcutaneous
- Dose
- 300 mcg – 500 mcg
- Cycle
- 8–16 weeks
Semaglutide
Semaglutide is a GLP-1 receptor agonist peptide that suppresses appetite, increases satiety, and improves glucose metabolism for pharmaceutical-grade weight loss and blood sugar control, achieving average weight loss of 15-18% body weight (30-40+ pounds) over 6 months in individuals with obesity or diabetes through sustained once-weekly injections or oral dosing. FDA-approved for both type 2 diabetes (as Ozempic) and weight management (as Wegovy), it outperforms all prior GLP-1 agonists including liraglutide with superior efficacy and sustained action.
- Route
- Subcutaneous
- Dose
- 250 mcg – 2.4 mg
- Cycle
- Long-term management involves titrating to maintenance
Semax
Semax is a neuropeptide derived from ACTH with unparalleled ability to simultaneously enhance focus, memory, learning, motivation, and neuroprotection by upregulating BDNF, optimizing dopamine/serotonin balance, improving cerebral blood flow, and suppressing neuroinflammation—essentially optimizing cognitive capacity across all domains simultaneously. Research shows 30-50%+ improvements in attention, memory, motivation, and stress resilience with cognitive enhancement maintained long-term without tolerance development or crash upon discontinuation.
- Route
- Subcutaneous
- Dose
- 300 mcg – 800 mcg
- Cycle
- 12–16 weeks
Sermorelin
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that naturally stimulates your pituitary gland to produce and release its own growth hormone rather than supplying synthetic GH directly—preserving your endocrine system’s feedback loops and natural hormone rhythms for sustainable, side-effect-minimal hormone optimization. Clinical research shows 82-107% increases in GH levels sustained for approximately 2 hours, translating to 28% IGF-1 elevation supporting muscle growth, fat loss, collagen synthesis, and comprehensive anabolic benefits with a 16-week treatment period.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 3–6 months
SS-31
SS-31 is a mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively penetrates mitochondrial membranes to bind cardiolipin, stabilizing cristae architecture, optimizing electron transport chain efficiency, and preventing reactive oxygen species (ROS) leakage at the source—delivering 20-40% ATP production increases while reducing oxidative damage across aging tissues. Unlike broad antioxidants that fail to reach mitochondria, SS-31’s cationic structure ensures compartmentalized action where 90% of cellular energy and ROS generation occurs, preserving Complex I-IV function and ADP sensitivity impaired in sarcopenia and neurodegeneration.
- Route
- Subcutaneous
- Dose
- 5 mg – 10 mg
- Cycle
- 8–12 weeks
TB-500 (Thymosin Beta-4)
Thymosin Beta-4
TB-500, the synthetic 43-amino-acid version of Thymosin Beta-4, accelerates tissue repair by upregulating actin polymerization, promoting cell migration, angiogenesis, and anti-inflammatory cytokine profiles—achieving 61% wound re-epithelialization by day 7 versus saline controls while preventing scar formation through collagen organization. It sequesters actin monomers to facilitate cytoskeletal remodeling essential for endothelial cell movement, fibroblast proliferation, and myocyte regeneration across skin, muscle, tendon, ligament, heart, and cornea.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1 mg
- Cycle
- 8–12 weeks
Tesamorelin
Tesamorelin acetate · GHRH(1-44)
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary to release its own growth hormone, achieving FDA-approved clinical efficacy for HIV-associated lipodystrophy with 15-20% visceral adipose tissue (VAT) reduction over 26 weeks—preferentially targeting dangerous abdominal fat while preserving subcutaneous fat and lean muscle mass, a metabolic selectivity unique among weight loss therapies.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 12–26 weeks
Thymosin Alpha-1
Thymosin α1 · Thymosin-α1
Thymosin Alpha-1 is a 28-amino-acid immunomodulatory peptide that enhances T-cell maturation into CD4+ and CD8+ subsets, activates natural killer (NK) cells, increases major histocompatibility complex (MHC) antigen expression on infected cells for improved viral recognition, and suppresses pro-inflammatory cytokines IL-1β and TNF-α to prevent cytokine-storm pathology—yielding superior antiviral efficacy across hepatitis B/C, HIV, and COVID-19 without immunosuppression risks.
- Route
- Subcutaneous
- Dose
- 300 mcg – 500 mcg
- Cycle
- 8–12 weeks
Tirzepatide
LY3298176 · Tilpotide
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide combining glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) mechanisms to deliver superior weight loss and metabolic improvement versus single-agonist therapy, achieving 20.9% weight loss (40-50+ pounds) over 18 months with HbA1c reductions of 2.58% in type 2 diabetes—the most potent single metabolic agent currently available.
- Route
- Subcutaneous
- Dose
- 2.5 mg – 7.5 mg
- Cycle
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
5-Amino-1MQ is a special tiny molecule that acts like a helper in your body, targeting fat storage and energy use. Imagine it as a smart switch that turns down an enzyme called NNMT, which normally slows your metabolism and helps fat cells grow.
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
Acetyl Hexapeptide-3 (Argireline)
Argireline · Acetyl Hexapeptide-3
Research Goal: Evaluate the non-invasive reduction of muscle contraction-induced skin wrinkling via inhibition of the SNARE complex.
- Route
- Topical
- Dose
- —
- Cycle
- 30 days for primary assessment
Adamax
Adamax is an enhanced Semax analog featuring N-terminal adamantane acetylation and C-terminal amidation modifications that extend half-life, improve blood-brain barrier penetration, and amplify BDNF expression, neuroplasticity, and cognitive enhancement compared to parent Semax—delivering sustained focus, memory consolidation, and neuroprotection through superior receptor binding affinity and metabolic stability. Structural upgrades enable lower dosing for equivalent or superior effects, targeting ACTH-derived pathways with prolonged receptor occupancy.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
Adipotide (FTPP)
FTPP · Adipotide
Research Goal: Investigating the induction of fat loss through targeted destruction of blood vessels supplying white adipose tissue.
- Route
- Subcutaneous
- Dose
- 5 mcg – 20 mcg
- Cycle
- 21–28 days; monitoring of renal markers is standard
AHK (Tripeptide-3)
Tripeptide-3 · AHK
AHK, or Tripeptide-3, is a small hair-growth peptide that mimics natural signals in your scalp to wake up follicles and strengthen strands. It boosts blood flow and key growth factors, helping thin or shedding hair get thicker and healthier.
- Route
- Topical
- Dose
- 500 mcg – 1 mg
- Cycle
- 8–12 weeks
AHK-Cu
GHK-Cu · Copper Tripeptide-1
AHK-Cu is the copper-charged version of AHK, supercharging hair and skin repair with its metal boost. The copper helps deliver growth signals deeper, stimulating follicles for thicker, faster-growing hair while also healing wounds and reducing inflammation.
- Route
- Topical
- Dose
- —
- Cycle
- —
AICAR
Acadesine · AICA-Riboside
AICAR is an exercise-mimicking peptide that tricks your body into workout mode without moving a muscle. It activates a pathway called AMPK, which ramps up fat burning, boosts endurance, and improves heart health—like a molecular personal trainer.
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
B7-33
B7-33 peptide · RXFP1 agonist B7-33
B7-33 is a heart-healing peptide that stops the scarring process in your heart, lungs, kidneys, and liver—organs that can be permanently damaged by chronic disease or injury. Fibrosis, the medical term for organ scarring, is like your body’s attempt at repair that goes wrong, creating stiff scar tissue instead of healthy tissue.
- Route
- Subcutaneous
- Dose
- 150 mcg – 500 mcg
- Cycle
- 4–8 weeks for acute fibrosis studies
Bronchogen
AEDL · Ala-Glu-Asp-Leu peptide
Bronchogen is a specialized lung-healing peptide that repairs damaged respiratory tissue and turns down inflammation deep in your airways. If you’ve ever struggled with chronic coughing, shortness of breath, or that feeling of heaviness in your chest from ongoing inflammation, Bronchogen targets the root cause at the cellular level.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; often repeated every 4–6 months
Cardiogen
AEDR · Ala-Glu-Asp-Arg peptide
Cardiogen is a heart-repair peptide that reverses the scarring and muscle weakness that make your heart fail or struggle after a heart attack. Unlike blood pressure pills that only manage symptoms, Cardiogen actually rebuilds heart muscle cells, preventing them from dying during stress, and blocks excessive scar formation that stiffens and weakens your heart over time.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Carnitine
Carnitine (L-carnitine) is a quaternary ammonium compound facilitating long-chain fatty acid transport into mitochondria for β-oxidation, increasing fat utilization by 20-50% during exercise while sparing glycogen and reducing lactate accumulation—essential for energy production in cardiac/skeletal muscle and preventing carnitine deficiency syndromes.[conversation context] Therapeutic doses (2-4g daily) enhance fat loss, exercise recovery, and insulin sensitivity in metabolic disorders.
- Route
- Subcutaneous
- Dose
- 50 mg – 100 mg
- Cycle
- 8–12 weeks
Cartalax
AED · Ala-Glu-Asp
Cartalax is a joint-rescue peptide formulated to rebuild cartilage, reduce joint inflammation, and restore the mobility you lose with age or arthritis. Made from a simple three-amino-acid sequence, it’s deceptively powerful—it activates genes responsible for producing collagen, the structural protein that gives cartilage its cushioning strength and flexibility.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Chonluten
Chonluten is a lung and respiratory peptide that awakens your lungs’ natural self-repair system and calms the chronic inflammation that keeps you wheezing and short of breath. If you’ve dealt with asthma, COPD, chronic bronchitis, or lingering damage from infection, Chonluten works at the genetic level to activate the genes responsible for rebuilding lung tissue.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
CJC-1295 (No DAC), GHRP-2
No DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) and GHRP-2 together form a synergistic growth hormone combo that naturally boosts your body’s muscle-building, fat-burning, and recovery superpowers. CJC-1295 without DAC mimics your brain’s natural growth hormone-releasing hormone, creating quick pulses of growth hormone release that mirror your body’s youthful rhythm (the natural surge during deep sleep).
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–16 weeks
CJC-1295 (No DAC), GHRP-6
No DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) paired with GHRP-6 creates a powerful dual-action growth hormone stimulation system that boosts muscle growth, burns fat, accelerates healing, and provides surprising cardiac and systemic protection benefits. Like the GHRP-2 version, this combination works through complementary pathways: CJC-1295 triggers pulsatile growth hormone release mimicking your body’s natural rhythms, while GHRP-6 raises the baseline level of GH and activates additional protective pathways beyond just hormone elevation.
- Route
- Subcutaneous
- Dose
- 100 mcg – 150 mcg
- Cycle
- 8–12 weeks
CJC-1295 (no DAC), Hexarelin
no DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) combined with Hexarelin creates a high-potency growth hormone stack that delivers powerful muscle growth, fat loss, and recovery benefits through synergistic hormone pulses. CJC-1295 without DAC acts like a natural signal from your brain to release growth hormone in short, strong bursts that mimic your body’s youthful sleep-time surges.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 4–6 weeks (shorter cycles prevent receptor desensitization)
CJC-1295 (No DAC), Ipamorelin, GHRP-2
No DAC · CJC-1295 (No DAC)
This triple peptide blend—CJC-1295 (No DAC), Ipamorelin, and GHRP-2—represents a premium growth hormone optimizer that multiplies natural GH release through three complementary pathways for superior muscle building, fat metabolism, and recovery. CJC-1295 triggers the main GH pulse like your body’s sleep signal, Ipamorelin provides clean, selective GH stimulation without hunger or prolactin spikes, and GHRP-2 adds extra amplification for even higher peaks.
- Route
- Subcutaneous
- Dose
- 100 mcg – 600 mcg
- Cycle
- 12–16 weeks
Cortagen
Cortagen is a brain-protecting peptide derived from cortex proteins that repairs neural damage, boosts learning, and shields your nervous system from stress or aging decline. It works by upregulating neurotrophic factors like BDNF (brain-derived neurotrophic factor), which grow and protect neurons while enhancing synaptic plasticity—the brain’s ability to form new connections for memory and skills.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 4 weeks
Decapeptide-12
Research Goal: Evaluation of melanogenesis inhibition for the treatment of melasma and post-inflammatory hyperpigmentation.
- Route
- Topical
- Dose
- —
- Cycle
- 12–16 weeks for visible pigment shift
Dihexa
Research Goal: Analyzing the potential for cognitive enhancement and synaptic repair in neurodegenerative models.
- Route
- Topical
- Dose
- 5 mg – 20 mg
- Cycle
- 4–8 weeks
FGL-S
FGL-S is a brain-boosting peptide derived from neural cell adhesion molecules that enhances memory, learning, and neural repair by strengthening connections between brain cells. It mimics natural signals to increase neurotransmitter release, promote new synapse formation, and protect against damage from stress, toxins, or injury.
- Route
- Subcutaneous
- Dose
- 2 mg – 10 mg
- Cycle
- 4–6 weeks
Follistatin 315
Research Goal: Assessing the inhibition of TGF-β ligands, specifically myostatin and activin A, for muscle growth acceleration.
- Route
- Subcutaneous
- Dose
- 100 mcg
- Cycle
- 10–30 days, followed by a significant washout period (4–8 weeks)
Follistatin 344
Research Goal: Evaluate the suppression of myostatin (GDF-8) to facilitate rapid skeletal muscle cell proliferation and lean mass accrual.
- Route
- Subcutaneous
- Dose
- 100 mcg
- Cycle
- 10–20 days per cycle, followed by a 4-week washout
FOX04-DRI (Proxofim)
Proxofim
FOX04-DRI, also known as Proxofim, is a senolytic peptide that selectively kills zombie-like senescent cells—aged, dysfunctional cells that accumulate with time, causing inflammation, tissue stiffness, and organ decline. By disrupting FOXO4-p53 interactions, it forces these cells into apoptosis while sparing healthy ones, rejuvenating tissues at the biological age level.
- Route
- Subcutaneous
- Dose
- 2 mg
- Cycle
- 2–6 weeks (intermittent dosing)
GHK Basic
GHK Basic is a simple yet powerful tripeptide (three amino acids: glycine, histidine, and lysine) that naturally declines with age, explaining why your skin loses firmness and wounds heal slower after 40. It works by modulating gene expression to boost collagen production, suppress inflammatory signals, reduce dangerous free radicals, and activate protective antioxidant enzymes—essentially flipping the switch on your body’s self-repair programs.
- Route
- Topical
- Dose
- 2 mg – 5 mg
- Cycle
- 4–8 weeks
GHRH
GHRH, or Growth Hormone-Releasing Hormone, is your brain’s master signal that tells your pituitary gland to make and release growth hormone in healthy, pulsatile patterns that mirror youthful sleep cycles. Produced naturally in a small brain region called the hypothalamus, it controls far more than just muscle growth—GHRH also regulates metabolism, bone density, immune function, sleep quality, and cognitive sharpness.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12 weeks
GHRP-2
GHRP-2 is a powerful growth hormone secretagogue that mimics ghrelin (your “hunger hormone”) to stimulate dramatic GH release while also genuinely increasing appetite and food intake—useful for people with wasting, poor appetite, or recovery needs. It activates the same receptor as ghrelin, causing pituitary cells to release stored GH and promote new GH synthesis, creating GH spikes up to 36-fold higher than normal.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
GHRP-6
GHRP-6 is another potent ghrelin mimetic that powerfully boosts growth hormone release while offering unique tissue protection and healing benefits beyond typical GH peptides. Like GHRP-2, it triggers massive GH spikes (up to 10-60 fold baseline), but GHRP-6 additionally activates CD36 receptors that reduce cell death from stress and damage—essentially protecting your organs and tissues from harm.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
Gonadorelin
Gonadorelin, also called GnRH (Gonadotropin-Releasing Hormone), is your brain’s master switch for reproductive hormones, naturally stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from your pituitary gland. These two hormones control testosterone production in men, estrogen and progesterone in women, and fertility in both sexes.
- Route
- Subcutaneous
- Dose
- 250–1000 IU
- Cycle
- 8–16 weeks
Hexarelin
Research Goal: Analyzing peak GH pulse amplitude and the protective effects of Hexarelin on cardiac myocytes via CD36 receptors.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 4 weeks on, followed by a 4-week washout to maintain pituitary sensitivity
HGH Fragment 176-191
HGH Fragment 176-191 is the isolated fat-burning region of human growth hormone, engineered specifically to target stubborn fat while avoiding the water retention, insulin resistance, and muscle-loss side effects of full GH. This 16-amino-acid sequence was identified as the exact region responsible for lipolysis—fat cell breakdown—making it remarkably selective for fat loss without systemic hormonal disruption.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
HGH Fragment, CJC-1295 (No DAC), Ipamorelin
No DAC · HGH Fragment 176-191
This triple stack—HGH Fragment 176-191 for targeted fat loss, CJC-1295 (No DAC) for natural GH pulses, and Ipamorelin for clean amplification—creates comprehensive body recomposition by burning stubborn fat while preserving and building lean muscle. The Fragment mimics growth hormone’s fat-mobilizing region, accelerating lipolysis especially in the abdomen without affecting blood sugar.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 8–12 weeks
HGH Fragment, Modified GRF, Ipamorelin
HGH Fragment 176-191 · hGH Frag 176-191
HGH Fragment 176-191 combined with Modified GRF (CJC-1295 No DAC) and Ipamorelin creates a triple-action body recomposition system that burns fat aggressively while preserving muscle and amplifying growth hormone at multiple levels. The Fragment targets the specific fat-burning region of growth hormone without affecting blood sugar or hormones, Modified GRF triggers natural pulsatile GH release mimicking your body’s youthful pattern, and Ipamorelin amplifies those pulses cleanly.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 8–12 weeks
HMG (Human Menopausal Gonadotropin)
Human Menopausal Gonadotropin
HMG is a purified extract from postmenopausal urine containing bioactive FSH (75IU) and LH (75IU) per vial, stimulating follicular development and ovulation induction in infertility protocols—achieving 80-90% ovulation rates and 30-40% pregnancy success in anovulatory women via multi-follicular recruitment.[conversation context] Unlike recombinant gonadotropins, HMG’s natural FSH/LH ratio mimics physiologic synergy for IVF/ICSI cycles.
- Route
- Subcutaneous
- Dose
- 0.15–75 IU
- Cycle
- 12–16 weeks
Humanin
Humanin is a revolutionary mitochondrial-derived peptide that extends lifespan and healthspan by protecting your cells from aging damage, boosting brain health, and optimizing metabolic function at the most fundamental level. It works by activating survival pathways in your mitochondria—your cells’ power plants—protecting them from oxidative stress and dysfunction that accelerates aging and disease.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1 mg
- Cycle
- 20–30 days
IGF-1 DES
IGF-1 DES is a modified version of insulin-like growth factor 1 with enhanced muscle-building and fat-loss properties due to its longer systemic activity compared to natural IGF-1, which only works for minutes. The DES modification preserves all anabolic effects while improving stability, allowing it to circulate longer and deliver more cumulative growth signals to muscle and fat cells.
- Route
- Subcutaneous
- Dose
- 25 mcg – 100 mcg
- Cycle
- 4 weeks on, followed by 4 weeks off
Livagen
Livagen is an immune-rejuvenating peptide related to Epitalon that awakens dormant genes in your immune cells and restores youthful immune function by literally repackaging DNA in lymphocytes from tightly sealed (aged) to accessible (youthful). It induces chromatin decondensation—unpacking DNA—which reactivates silenced genes related to protein production and immune cell activity that naturally shut down with aging.
- Route
- Subcutaneous
- Dose
- 500 mcg – 2 mg
- Cycle
- 8–12 weeks
Matrixyl
Matrixyl is a palmitoyl-pentapeptide (five-amino-acid peptide with a fatty chain) that signals skin fibroblasts to dramatically increase collagen production and strength, reversing the collagen loss that causes wrinkles, sagging, and thin texture as you age. It works by binding to cell surface receptors and triggering signaling cascades similar to TGF-β pathways that activate collagen synthesis while simultaneously inhibiting collagen-degrading enzymes.
- Route
- Topical
- Dose
- —
- Cycle
- Minimum 60–90 days for extracellular matrix remodeling
Mazdutide
Mazdutide is China’s first approved dual GLP-1/glucagon receptor agonist for obesity, delivering 14.8% weight loss at 6mg weekly (48 weeks) via appetite reduction plus increased energy expenditure targeting liver, brain, and adipose remodeling—83% of patients achieve ≥5% loss versus 11.5% placebo, with 50.6% reaching ≥15%. Lilly/Innovent collaboration yields first-in-class GCG/GLP-1 synergy, enhancing fat oxidation beyond GLP-1 alone.
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 8–12 weeks
Melanostatin DM
Melanostatin DM is a skin-brightening peptide that inhibits alpha-MSH (the hormone that controls melanin production), effectively lightening skin tone and evening out discoloration without bleaching side effects. It works by blocking the signals that tell melanocytes (pigment cells) to produce melanin, preventing tyrosinase enzyme activation—the critical step in melanin synthesis.
- Route
- Topical
- Dose
- —
- Cycle
- 8–12 weeks
Melanotan 1 (MT1)
MT1
Melanotan 1 is a synthetic melanocortin peptide that dramatically increases melanin production to create a deep, prolonged tan with minimal sun exposure—offering genuine UV protection alongside cosmetic tanning effects. It binds to melanocortin-1 receptors on melanocytes, stimulating both melanocyte proliferation and tyrosinase activity to boost melanin production and skin darkening.
- Route
- Subcutaneous
- Dose
- 500 mcg – 2 mg
- Cycle
- Indefinite during tanning months; requires moderate UV stimulus to activate
Melanotan 2 (MT2)
MT2
Melanotan 2 is a synthetic melanocortin agonist that powerfully stimulates melanin production for rapid, deep tanning while simultaneously boosting libido and sexual function through activation of multiple melanocortin receptors. Unlike Melanotan 1, which primarily targets skin pigmentation via MC1R, MT2 activates MC3R and MC4R in the brain, creating appetite suppression in some users alongside pronounced erectile enhancement and spontaneous arousal—effects that make it uniquely dual-purpose for cosmetic tanning and sexual wellness.
- Route
- Subcutaneous
- Dose
- 250 mcg – 1 mg
- Cycle
- 6–8 weeks
MGF (Mechano Growth Factor)
Mechano Growth Factor
Mechano Growth Factor (MGF) is a splice variant of IGF-1 expressed specifically in response to mechanical stress like weight training, activating muscle satellite stem cells to repair micro-tears and drive hypertrophy beyond natural limits. Released post-workout from damaged muscle fibers, it recruits stem cells to fuse with existing myofibrils, adding nuclei for greater protein synthesis capacity and rapid tissue remodeling—explaining why heavy resistance training builds muscle faster than any other stimulus.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
MK-677
MK-677 (Ibutamoren) is an oral growth hormone secretagogue that mimics ghrelin to continuously elevate GH and IGF-1 levels for 24 hours daily, delivering sustained anabolic effects without injections or pituitary suppression. Unlike peptides requiring multiple doses, MK-677 provides steady-state hormone elevation, improving nitrogen retention, deep sleep quality, and connective tissue strength for comprehensive body recomposition and anti-aging.
- Route
- Oral
- Dose
- 12.5 mg – 50 mg
- Cycle
- 12–16 weeks; monitoring of fasting blood glucose is standard
Mod GRF, GHRP-2
Mod GRF (1-29) · Modified GRF (1-29)
The Mod GRF (1-29)/GHRP-2 blend combines sustained GH pulse amplification with powerful secretagogue action, producing synergistic 50-fold GH spikes that dramatically exceed either peptide alone for superior muscle growth, fat loss, and recovery. Mod GRF provides the prolonged receptor stimulation mimicking natural GHRH, while GHRP-2 aggressively amplifies pituitary response via ghrelin mimicry, creating the most potent injectable GH elevation available.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–16 weeks
Mod GRF, GHRP-6
Mod GRF (1-29) · Modified GRF (1-29)
Mod GRF/GHRP-6 synergistically unleashes massive GH pulses through complementary mechanisms—Mod GRF extending signal duration while GHRP-6 provides intense ghrelin-mediated spikes—ideal for aggressive muscle building and appetite enhancement during bulking phases. The combination overcomes individual limitations, delivering prolonged, high-amplitude GH release mimicking peak youthful physiology.
- Route
- Subcutaneous
- Dose
- 100 mcg – 150 mcg
- Cycle
- 8–12 weeks
Mod GRF, Hexarelin
Mod GRF/Hexarelin represents peak GH secretagogue potency, combining sustained GHRH agonism with Hexarelin’s extreme receptor affinity for explosive, sustained GH elevation supporting maximal hypertrophy and strength. The blend produces among the highest recorded GH peaks, with neuroprotective and cardiovascular benefits from Hexarelin’s unique profile.
- Route
- Subcutaneous
- Dose
- 100 mcg – 150 mcg
- Cycle
- 4 weeks on, followed by a 4-week washout period
Mod GRF, Ipamorelin
The Mod GRF/Ipamorelin combination represents the cleanest, most physiologic growth hormone secretagogue stack available, delivering sustained GH elevation without appetite stimulation, cortisol spike, or receptor desensitization—ideal for fat loss, recovery, and longevity. Mod GRF (CJC-1295 No DAC) provides prolonged GHRH stimulation extending GH pulse duration, while Ipamorelin gently amplifies the pituitary’s release via ghrelin mimicry without the side effects of aggressive secretagogues, creating a synergistic rhythm mimicking youthful sleep-phase GH secretion.
- Route
- Subcutaneous
- Dose
- 167 mcg – 333 mcg
- Cycle
- 12–16 weeks
Mod GRF, Ipamorelin, GHRP-2
The triple blend of Mod GRF, Ipamorelin, and GHRP-2 creates ultimate GH pulse architecture—sustained amplitude from Mod GRF, clean selectivity from Ipamorelin, and raw power from GHRP-2—for comprehensive body recomposition without cortisol disruption or excessive hunger. Multi-pathway activation yields 10x+ GH elevation with metabolic optimization.
- Route
- Subcutaneous
- Dose
- 300 mcg – 450 mcg
- Cycle
- 12–16 weeks
N-Acetyl Epithalon Amidate
Research Goal: Assessing the activation of telomerase and the modulation of melatonin secretion through the pineal-hypothalamic axis with an acetylated/amidated derivative.
- Route
- Subcutaneous
- Dose
- 5 mg – 10 mg
- Cycle
- 10–20 days; typically repeated only once or twice per year
N-Acetyl Selank Amidate
Research Goal: Evaluating the modulation of the serotonin and dopamine systems for the treatment of generalized anxiety and cognitive fatigue.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 14–30 days
N-Acetyl Semax Amidate
Research Goal: Analyzing the neuroprotective and nootropic properties of the stabilized Semax analog in models of ischemic stroke or ADHD.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 10–30 days
Nonapeptide-1
Research Goal: Evaluation of localized melanin suppression for skin brightening and the treatment of post-inflammatory hyperpigmentation.
- Route
- Topical
- Dose
- —
- Cycle
- 8–12 weeks for observable changes in pigmentation
Orforglipron
Research Goal: Analyzing the efficacy of a small-molecule GLP-1RA for gastric emptying inhibition and satiety signaling via oral administration.
- Route
- Oral
- Dose
- 12 mg – 45 mg
- Cycle
- Chronic administration for metabolic research
OS-01
Peptide 14 · Peptide OS-01
OS-01 is the first peptide scientifically proven to reduce cellular senescence—the accumulation of aged, dysfunctional cells that drive visible aging and disease—by directly targeting this fundamental aging mechanism in skin. Laboratory studies show OS-01 reduces senescence marker CDKN2A by 50% in human skin samples and reversed the biological age of ex vivo skin samples by 2.5 years in just 5 days, an unprecedented achievement demonstrating genuine cellular age reversal rather than cosmetic concealment.
- Route
- Topical
- Dose
- —
- Cycle
- 12+ weeks for measurable changes in skin "biological age."
Ovagen
Ovagen is a Khavinson tripeptide bioregulator (Glu-Asp-Leu) primarily targeting liver and gastrointestinal tract function by directly modulating gene transcription patterns, resetting aged DNA to more youthful expression profiles that restore cellular resilience and repair capacity. Unlike pharmaceutical drugs that block or activate single targets, Ovagen penetrates cell and nuclear membranes to systematically reprogram gene expression, promoting hepatic cell proliferation while preventing cirrhotic scarring, and supporting mucosal barrier protection in the GI tract against antibiotics, chemotherapy, environmental toxins, and malnutrition.
- Route
- Subcutaneous
- Dose
- 10 mcg – 50 mcg
- Cycle
- 1–2 weeks (Note: Preclinical research often utilizes shorter cycles or maintenance phases)
Oxytocin
Oxytocin is the “bonding peptide” hormone that orchestrates social connection, trust, empathy, mother-infant attachment, sexual pleasure, and childbirth through activation of specific brain regions controlling reward and emotion. Released naturally during social contact, sexual activity, childbirth, and breastfeeding, it creates positive feedback loops where contact triggers oxytocin release, reinforcing bonds and motivation for further connection.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 8–12 weeks
P21 (P021)
P021
P21 is a tetrapeptide cyclin-dependent kinase (CDK) inhibitor derived from ciliary neurotrophic factor (CNTF) that blocks cell cycle progression by inhibiting CDK-cyclin complexes, triggering apoptosis (programmed cell death) in senescent and cancer cells while allowing healthy cells to continue dividing. It functions as a selective checkpoint regulator, preventing damaged or aged cells from replicating while permitting normal cellular division—essentially quality control for your cellular population.
- Route
- Subcutaneous
- Dose
- 10 mg – 30 mg
- Cycle
- 4–10 weeks
Pal-AHK
Pal-AHK is a palmitoyl-conjugated tripeptide (alanine-histidine-lysine) that dramatically stimulates collagen synthesis by activating fibroblasts through transforming growth factor-beta (TGF-β) signaling, with research suggesting up to 300% increases in collagen type I production compared to untreated controls. The palmitoyl fatty acid tail markedly improves skin penetration and cellular absorption, allowing AHK to reach deeper dermal layers where collagen synthesis occurs, far surpassing non-lipidated versions.
- Route
- Topical
- Dose
- —
- Cycle
- 8–16 weeks
Pal-GHK (Palmitoyl Tripeptide-1)
Palmitoyl Tripeptide-1
Research Goal: Analyzing the synthesis of Type I Collagen and Fibronectin in the extracellular matrix to improve skin firmness and elasticity.
- Route
- Topical
- Dose
- —
- Cycle
- 4–8 weeks for visual results
Palmitoyl Dipeptide-6
Research Goal: Investigating the structural integrity of the skin-to-muscle/fat connection and the improvement of nutrient exchange across the DEJ.
- Route
- Topical
- Dose
- —
- Cycle
- 12 weeks
Pancragen
Pancragen is a tetrapeptide bioregulator (Lys-Glu-Asp-Trp) that restores pancreatic cell function by penetrating cell membranes to reprogram DNA transcription patterns, specifically upregulating genes critical for pancreatic maturation (Ptf1a, Pdx1, Pax6) while suppressing apoptotic signals that destroy pancreatic cells. Research shows it reduces fasting glucose by up to 40%, normalizes insulin secretion dynamics, and improves glucose utilization efficiency—effects that persist weeks after treatment concludes, suggesting genuine gene expression resets rather than temporary suppression.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; typically repeated every 4–6 months
PE-22-28
PE-22-28 is a neuropeptide derived from vasoactive intestinal peptide (VIP) that acts as a rapid-onset antidepressant by blocking TREK-1 potassium channels in mood-regulating brain regions, enhancing neuronal excitability and serotonergic transmission through distinct mechanisms differing from all current antidepressants. This fundamentally different mechanism may explain its potential for treatment-resistant depression where traditional SSRIs fail, offering hope for 30-40% of depressed individuals currently unresponsive to conventional drugs.
- Route
- Subcutaneous
- Dose
- 50 mcg – 200 mcg
- Cycle
- 12–16 weeks
PEG MGF
Research Goal: Investigating the induction of muscle hyperplasia and the repair of damaged skeletal muscle tissue via the E-domain of IGF-1.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 4–6 weeks
Pentapeptide-18 (Leuphasyl)
Leuphasyl
Research Goal: Analyzing the inhibition of calcium influx across the neuron membrane to reduce glutamate release and muscle contraction.
- Route
- Topical
- Dose
- —
- Cycle
- 28–60 days for measurable depth reduction
PNC-27
PNC-27 is a groundbreaking anti-cancer peptide that selectively kills cancer cells by binding to HDM-2 protein on cancer cell membranes, then forming transmembrane pores that trigger immediate necrotic cell death through osmotic lysis—without requiring p53 tumor suppressor genes, allowing it to work against p53-null cancers resistant to conventional therapy. Laboratory studies show nearly 100% cancer cell elimination in leukemia and breast cancer lines while leaving normal cells completely unharmed due to HDM-2 expression exclusively on cancer cell membranes.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 8–12 weeks
Prostamax
Prostamax is a tetrapeptide bioregulator (derived from prostate tissue) that reduces chronic prostate inflammation by suppressing immune cell infiltration and vascular congestion while simultaneously promoting prostate cell repair through epigenetic gene regulation. Research in animal models shows 15-day treatment reduces swelling, lymphocyte infiltration, and scarring in chronic prostatitis, restoring normal urinary flow and function without blocking hormones like 5-alpha reductase inhibitors.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1 mg
- Cycle
- 8–12 weeks
Rigin (Palmitoyl Tetrapeptide-7)
Palmitoyl Tetrapeptide-7
Research Goal: Assessing the "Anti-Aging" cytokine effect to preserve collagen and elastin by mimicking the action of DHEA in the skin.
- Route
- Topical
- Dose
- —
- Cycle
- 8 weeks
Sermorelin, GHRP-2
Sermorelin combined with GHRP-2 creates a dual-mechanism growth hormone amplification stack where Sermorelin acts as the “on switch” via GHRH receptor activation to trigger GH production and release, while GHRP-2 acts as the “volume knob” via ghrelin receptor agonism to amplify the pituitary’s GH response and frequency—together producing 10-20 fold higher GH elevation than either peptide alone.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–16 weeks
Sermorelin, GHRP-6
Sermorelin paired with GHRP-6 delivers sustained GH elevation alongside GHRP-6’s unique appetite-stimulating and cardioprotective properties, making it ideal for bulking phases where caloric surplus is critical for muscle gain. Sermorelin triggers GH production via natural GHRH pathways while GHRP-6 amplifies release and provides appetite enhancement and additional anti-inflammatory benefits promoting rapid tissue repair.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 8–12 weeks
Sermorelin, GHRP-6, GHRP-2
The triple-peptide stack of Sermorelin, GHRP-6, and GHRP-2 combines all three complementary growth hormone pathways simultaneously—Sermorelin triggering production via GHRH, GHRP-6 amplifying release plus appetite and anti-inflammatory support, and GHRP-2 providing additional secretagogue power and muscle-structural enhancement. While individual addition doesn’t yield proportionally greater GH spikes than dual stacks, the combination provides multi-system benefits spanning muscle growth, fat loss, appetite support, inflammation reduction, cardiovascular protection, and metabolic optimization.
- Route
- Subcutaneous
- Dose
- 100 mcg – 600 mcg
- Cycle
- 12–16 weeks
Sermorelin, Ipamorelin
Sermorelin combined with Ipamorelin represents the cleanest, most physiologic growth hormone stack, where Sermorelin triggers immediate GH response via GHRH pathways (11-12 minute half-life for rapid effect) while Ipamorelin extends and sustains GH elevation via ghrelin agonism (2-hour half-life for sustained action). Sermorelin may increase GH 82-107% while Ipamorelin contributes additional sustained elevation and potentially adds 1000%+ amplification at its peak, combining immediate onset with sustained duration for complete GH curve optimization.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–24 weeks
SLU-PP-332
SLU-PP-332 is an oral estrogen-related receptor (ERR) agonist that mimics exercise at the molecular level, activating the same metabolic pathways as 30 minutes of intense cardio without requiring physical exertion—enabling metabolic transformation through gene expression alone. Preclinical studies show it reduces fat mass by 12% in diet-induced obesity models while preventing new fat gain (versus 5g gain in controls), dramatically improves glucose tolerance and insulin sensitivity, reverses hepatic steatosis (fatty liver disease), and reduces inflammatory markers in liver and adipose tissue—all without increasing physical activity or changing diet.
- Route
- Subcutaneous
- Dose
- 1.25 mg
- Cycle
- Research cycles typically span 4–8 weeks
SNAP-8
SNAP-8 (Acetyl Octapeptide-3) is a wrinkle-reducing peptide approximately 30% more potent than its parent peptide Argireline, working by mimicking SNAP-25 protein fragments to gently block neurotransmitter release at the neuromuscular junction, relaxing facial muscles without complete paralysis—reducing expression line depth by up to 63% within 28 days while preserving natural facial expressions.
- Route
- Subcutaneous
- Dose
- 330 mcg – 1 mg
- Cycle
- 8–12 weeks
Survodutide
Survodutide (BI 456906) is a dual GLP-1/glucagon receptor agonist engineered for superior obesity treatment, achieving 15-20% weight loss over 46 weeks through synergistic appetite suppression (GLP-1) and energy expenditure increase (glucagon), outperforming semaglutide in preclinical models with significant waist circumference and BMI reductions at doses >2mg weekly. Phase 2 trials confirm dose-dependent efficacy, with higher doses (>4.5mg) yielding maximal fat loss while preserving lean mass.
- Route
- Subcutaneous
- Dose
- 1.2 mg – 4.8 mg
- Cycle
Syn-AKE
Research Goal: Evaluation of the reversible inhibition of muscle contractions to smooth expression lines and prevent the formation of deep wrinkles.
- Route
- Topical
- Dose
- —
- Cycle
- 28–90 days for measurable topographic improvements
Syn-Coll (Palmitoyl Tripeptide-5)
Palmitoyl Tripeptide-5
Research Goal: Assessing the "Collagen Booster" effect by mimicking the human body’s own mechanism to activate latent TGF-β, leading to extracellular matrix remodeling.
- Route
- Topical
- Dose
- —
- Cycle
- 8–12 weeks
TB-500 Fragment (17-23)
17-23
Research Goal: Analyzing the localized repair of tendons, ligaments, and muscle tissue through the stimulation of actin sequestration and angiogenesis.
- Route
- Subcutaneous
- Dose
- 250 mcg – 500 mcg
- Cycle
- 4–8 weeks
Tesamorelin, CJC-1295 (No DAC), Ipamorelin
No DAC
This triple stack synergistically maximizes visceral fat reduction through Tesamorelin’s targeted abdominal lipolysis (15% waist circumference reduction in HIV lipodystrophy), CJC-1295’s sustained GH pulsatility (3-5x baseline elevation over 6-8 hours), and Ipamorelin’s clean GH amplification without cortisol/prolactin spikes—achieving superior IGF-1 increases (up to 200%) and metabolic optimization versus dual therapies. Tesamorelin selectively mobilizes trunk fat via hypothalamic GH axis stimulation, complemented by CJC-1295’s half-life extension and Ipamorelin’s pituitary synergy.
- Route
- Subcutaneous
- Dose
- 100 mcg – 1 mg
- Cycle
- 12–26 weeks
Tesamorelin, Ipamorelin
Tesamorelin paired with Ipamorelin targets visceral fat obliteration through Tesamorelin’s specific trunk adipose reduction (1.3kg fat mass loss over 26 weeks) amplified by Ipamorelin’s selective GH release (no appetite/cortisol elevation), creating sustained IGF-1 elevation for metabolic and anabolic benefits without DAC-related prolongation risks. Tesamorelin’s FDA-approved HIV lipodystrophy efficacy translates to general visceral fat targeting, enhanced by Ipamorelin’s clean secretagogue profile.
- Route
- Subcutaneous
- Dose
- 1 mg
- Cycle
- 12–26 weeks
Tesofensine
Tesofensine free base · NS-2330
Research Goal: Analyzing the suppression of appetite and increase in resting energy expenditure through the modulation of neurotransmitter reuptake in the hypothalamus.
- Route
- Oral
- Dose
- 250 mcg – 1 mg
- Cycle
- 12–24 weeks
Testagen
KEDG · Anterior Pituitary Peptide (APP)
Testagen is a peptide bioregulator that restores youthful testosterone production by directly modulating pituitary gene expression to increase luteinizing hormone (LH) and thyroid-stimulating hormone (TSH) release, triggering downstream testosterone and thyroid hormone synthesis—addressing the root endocrine dysregulation underlying age-related hormone decline rather than supplying testosterone externally.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
Thymagen (Thymogen)
Thymogen
Research Goal: Investigating the restoration of immune homeostasis and the stimulation of T-cell maturation in models of immunodeficiency.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 10 days; often repeated every 3–6 months
Thymalin
Thymulin · Nonathymulin
Research Goal: Assessing the geroprotective (anti-aging) and immunomodulatory effects of the full thymic extract complex on longevity and organ function.
- Route
- Subcutaneous
- Dose
- 10 mg – 20 mg
- Cycle
- 10 days per cycle, repeated 1–2 times per year
Thymulin
Thymulin (FTS) is a zinc-dependent nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted by thymic epithelial cells that matures intra- and extra-thymic T-cells, modulates cytokine production via cAMP/calcium signaling, and bridges immune-neuroendocrine communication—its activity requires equimolar zinc binding for conformational stability and receptor interaction. Zinc deficiency abolishes bioactivity, making serum thymulin a sensitive marginal zinc status marker correlating with T-cell dysfunction and lymphokine impairment.
- Route
- Route varies
- Dose
- —
- Cycle
- —
TRH Thyrotropin (Protirelin)
Protirelin
Research Goal: Analyzing the acute thyroid-stimulating hormone (TSH) response and the neuroprotective potential of TRH in central nervous system research.
- Route
- Subcutaneous
- Dose
- 200 mcg – 1 mg
- Cycle
- Short pulses only; chronic use can desensitize TSH receptors
Tripeptide-29
Gly-Pro-Hyp · H-Gly-Pro-Hyp-OH
Research Goal: Assessing immediate Type I collagen increase and dermal structural density via a small-molecule peptide with high bioavailability.
- Route
- Topical
- Dose
- —
- Cycle
- 4–8 weeks
Triptorelin
Triptoreline · Triptorelina
Research Goal: Analyzing pituitary desensitization and hormonal suppression or the "restart" (recovery) effect of a single pulse dose.
- Route
- Subcutaneous
- Dose
- 100 mcg – 3.75 mg
- Cycle
- Dependent on goal (One-time pulse vs. monthly suppression)
Vesilute
Vesilut · Glu-Asp
Research Goal: Evaluating the restoration of bladder wall muscle tone and epithelial tissue regeneration via peptide bioregulators.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; typically repeated every 3–6 months
Vesugen
Vesugen KED · KED tripeptide
Vesugen is a vascular-targeting peptide that penetrates endothelial cell membranes to activate Ki-67 and SIRT1 genes, upregulating longevity pathways and vascular regeneration signals while promoting collagen and elastin synthesis within blood vessel walls—achieving 53-61% improvements in vascular endothelial function and reversing age-related vascular stiffness through epigenetic gene expression modulation.
- Route
- Subcutaneous
- Dose
- 500 mcg – 2 mg
- Cycle
- 8–12 weeks
Vialox
Vialox (Pentapeptide-3) is a five-amino-acid peptide that relaxes facial muscles by blocking acetylcholine release at the neuromuscular junction, selectively binding to receptors and preventing sodium ion release—achieving 49-52% wrinkle reduction within 28 days through mechanisms similar to botulinum toxin but non-invasive and topically applied without paralysis or frozen appearance.
- Route
- Topical
- Dose
- —
- Cycle
- —
Vilon
Vilon is the shortest bioactive peptide (Lys-Glu, just 2 amino acids) that acts as a potent chromatin regulator, inducing heterochromatin unrolling and activating previously silenced genes related to immune function, cardiovascular health, gastrointestinal integrity, and tumor suppression—effectively “turning on” genes that aging has silenced without activating abnormal genetic programs. Research demonstrates that Vilon induces chromatin deheterochromatinization with simultaneous activation of synthetic processes through ribosomal gene reactivation.
- Route
- Subcutaneous
- Dose
- 67 mcg – 667 mcg
- Cycle
- Short 5-day pulses, often repeated every 3–6 months
VIP
Research Goal: Analyzing the regulation of cytokine secretion and improvement of blood flow in pulmonary or cerebral research.
- Route
- Subcutaneous
- Dose
- 50 mcg – 200 mcg
- Cycle
- 30 days